NEW DRUGS IN JAPAN

被引:0
|
作者
OGAWA, M [1 ]
机构
[1] JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,TOKYO 170,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:108 / 108
页数:1
相关论文
共 50 条
  • [1] Japan plans improved monitoring of new drugs
    Lamar, J
    [J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7249): : 1560 - 1560
  • [2] New drugs for Alzheimer's disease in Japan
    Takeda, Masatoshi
    Tanaka, Toshihisa
    Okochi, Masayasu
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 65 (05) : 399 - 404
  • [3] Tightened rules for testing new drugs in Japan
    不详
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (06) : 507 - 507
  • [4] Prevalence of New Designer Drugs and Their Legal Status in Japan
    Kikura-Hanajiri, Ruri
    Uchiyama, Nahoko
    Kawamura, Maiko
    Ogata, Jun
    Goda, Yukihiro
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2013, 133 (01): : 31 - 40
  • [5] Evolution of frameworks for expediting access to new drugs in Japan
    Fujiwara, Yasuhiro
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (05) : 293 - 294
  • [6] PRICE COMPARISON OF NEW DRUGS IN JAPAN, EU AND US
    Maruyama, M.
    Tsujimura, K.
    Kasahara, M.
    Yamabe, K.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A655 - A656
  • [7] Evolution of frameworks for expediting access to new drugs in Japan
    Yasuhiro Fujiwara
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 293 - 294
  • [8] OVERVIEW OF NEW ANTI-CANCER DRUGS OF INTEREST IN JAPAN
    TSUKAGOSHI, S
    [J]. CANCER TREATMENT REVIEWS, 1980, 7 (04) : 215 - 224
  • [9] NEW ANTICANCER DRUGS UNDER CLINICAL-TRIALS IN JAPAN
    OGAWA, M
    ARIYOSHI, Y
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (02) : 277 - 287
  • [10] A view on the new nomenclature from the perspective of the drugs developed in Japan
    Yamawaki, S.
    Hashimoto, H.
    Ikeda, K.
    Kato, T.
    Kanba, S.
    Ozaki, N.
    Kusumi, I.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 30 - 30